BridgeMD
New treatment option for Contrast-Associated Acute Kidney Injury
Official title Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED
ClinicalTrials.gov ID: NCT07459413
What this study is testing
- What it's testing
- This study is planned to be conducted by emergency physicians between November 7, 2025, and December 7, 2026. Inclusion and Exclusion Criteria The study will include adult patients aged 18 years and older who are considered at risk for Contrast-Associated Acute Kidney Injury (CA-AKI), with an estimated Glomerular Filtration Rate (eGFR) between 15-59 ml/min/1.73 m², a clinical indication for contrast-enhanced CT, and who have provided signed informed consent.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged 18 years and older.
- Patients with an estimated Glomerular Filtration Rate (eGFR) between 15-59 mL/min/1.73 m².
- Patients undergoing contrast-enhanced computed tomography (CT) in the emergency department.
- Patients who have provided written informed consent.
You likely can't join if
- Pregnant women.
- Patients with end-stage renal disease (ESRD) receiving dialysis or those with an eGFR \<15 mL/min/1.73 m².
- Patients presenting with decompensated heart failure.
- Patients with a known allergy to iodinated contrast media.
- Patients with contrast media exposure within the last 72 hours.
- Patients for whom oral intake is contraindicated or who cannot tolerate oral intake
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Gaziosmanpasa, Turkey (Türkiye)
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Gaziosmanpasa, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.